Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al.
| Field | Value | Language |
| dc.contributor.author | Vitetta, Luis | en |
| dc.contributor.author | Andersen, Tomas | en |
| dc.contributor.author | Quezada, Michelle | en |
| dc.contributor.author | Rutolo, Dave | en |
| dc.contributor.author | Henson, Jeremy D. | en |
| dc.date.accessioned | 2022-04-28T02:45:13Z | |
| dc.date.available | 2022-04-28T02:45:13Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://hdl.handle.net/2123/28363 | |
| dc.language.iso | en | en |
| dc.rights | Other | |
| dc.subject | COVID-19 | en |
| dc.subject | Coronavirus | en |
| dc.title | Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al. | en |
| dc.type | Other | en |
| dc.identifier.doi | 10.1089/can.2022.0034 | |
| usyd.faculty | Faculty of Medicine and Health | en |
Associated file/s
There are no files associated with this item.
Associated collections